Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-022685
Filing Date
2018-04-26
Accepted
2018-04-26 16:06:49
Documents
53
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv491272_10q.htm 10-Q 500173
2 EXHIBIT 31.1 tv491272_ex31-1.htm EX-31.1 8910
3 EXHIBIT 31.2 tv491272_ex31-2.htm EX-31.2 9404
4 EXHIBIT 32.1 tv491272_ex32-1.htm EX-32.1 5112
  Complete submission text file 0001144204-18-022685.txt   3775348

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT arth-20180331.xml EX-101.INS 732384
6 XBRL TAXONOMY EXTENSION SCHEMA arth-20180331.xsd EX-101.SCH 39408
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arth-20180331_cal.xml EX-101.CAL 22524
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arth-20180331_def.xml EX-101.DEF 244088
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arth-20180331_lab.xml EX-101.LAB 314379
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arth-20180331_pre.xml EX-101.PRE 312427
Mailing Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702
Business Address 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 617-431-2313
Arch Therapeutics, Inc. (Filer) CIK: 0001537561 (see all company filings)

EIN.: 460524102 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-54986 | Film No.: 18778543
SIC: 3841 Surgical & Medical Instruments & Apparatus